By Robert Preidt HealthDay Reporter FRIDAY, May 20, 2016 (HealthDay News)– An updated guideline adds two brand-new kinds of drugs to the list of treatment choices for cardiac arrest. In people with the condition, the heart cannot pump sufficient blood throughout the body. The 2 new treatments in the updated standards are an angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril), offered as Entresto, and a sinoatrial node modulator (ivabradine), offered as Corlanor, according to the American College of Cardiology, the American Heart Association and the Cardiac arrest Society of America. Formerly suggested drugs for these clients include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, beta blockers and diuretics. “Treatment alternatives for clients with heart failure have broadened considerably. There is more hope than ever before for patients with heart failure,” guideline update committee vice chair Dr. Mariell Jessup spokened in a press release from the heart groups. She is a teacher of medication at the University of Pennsylvania School of Medicine in Philadelphia. “These guideline recommendations will work as a tool to guide the option of treatment and, …
< a href=http://www.webmd.com/heart-disease/heart-failure/news/20160520/updated-heart-failure-treatment-guidelines-issued?src=RSS_PUBLIC target="_ blank
After Cardiac arrest, New Risk: Heart Failure By Robert Preidt HealthDay Press reporter TUESDAY, May 24, 2016 (HealthDay News)– Risk of cardiac arrest appears high within a few years of a first cardiovascular disease, a new study discovers. “Heart failure is a major medical issue with a high opportunity of hospitalization and death,” stated research study author Dr. Johannes Gho, a cardiology resident at the University Medical Center Utrecht in the Netherlands. Cardiac arrest suggests the heart cannot pump blood efficiently enough to satisfy the body’s needs. Enhanced cardiac arrest treatment has caused higher survival rates, leaving more clients prone to later heart failure, Gho spokened in a European Society of Cardiology news release. For the research study, researchers analyzed data from almost 25,000 individuals in the United Kingdom who suffered a first cardiovascular disease. Nearly 25 percent of these patients developed cardiac arrest within 4 years, the private investigators found. Certain risk factors increased the danger of heart failure after a very first cardiac arrest, Gho and his coworkers stated. For instance, every 10-year rise in age was connected with a 45 percent greater risk, and the poorest clients had a 27 percent increased risk. Atrial fibrillation– a condition characterized …
< a href=http://www.webmd.com/heart-disease/news/20160524/after-heart-attack-new-threat-heart-failure?src=RSS_PUBLIC target="_ blank
< a href=http://www.webmd.com/hypertension-high-blood-pressure/news/20160523/blood-pressure-swings-linked-to-faster-decline-in-mental-skills?src=RSS_PUBLIC target="_ blank
< a href=http://www.webmd.com/mental-health/addiction/news/20160526/fda-approves-implant-to-battle-opioid-addiction?src=RSS_PUBLIC target="_ blank
Path Through the Placenta Get information and examines on prescription drugs, non-prescription medications, vitamins, and supplements. Search by name or medical condition. Go into the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will show images that you can compare to your pill. Conserve your medication, check interactions, sign up for FDA signals, create family profiles and more. Talk to health experts and other individuals like you in WebMD’s Neighborhoods. It’s a safe forum where you can produce or take part in support groups and discussions about health subjects that interest you. FRIDAY, May 27, 2016 (HealthDay News)– Brand-new research study seems to clarify how the Zika virus contaminates, but does not eliminate, placenta cells. The mosquito-borne virus can trigger serious birth defects in infants whose mothers are exposed to Zika during pregnancy, but scientists have no idea precisely how that takes place. “Our results corroborate the minimal evidence from pathology case reports,” spokened senior author Mehul Suthar, an assistant teacher of pediatrics at Emory University School of Medicine, in Atlanta. “It was understood that the virus was getting into the placenta. But little was understood about where t.
See all stories on this topic